Neuroinflammation in Lyme Disease
Neuroinflammation in Lyme disease may help explain why symptoms such as brain fog, fatigue, and slowed thinking can persist—even when standard tests are normal and initial treatment has been completed.
Many patients describe difficulty concentrating, memory problems, and reduced mental clarity that interfere with daily life. These symptoms are increasingly understood as reflecting inflammation affecting the brain and nervous system rather than structural damage.
Neuroinflammation is closely linked to immune dysregulation in Lyme disease, where immune signaling remains altered and continues to affect neurologic function.
For a broader framework, see Persistent Lyme Disease Mechanisms.
What is neuroinflammation?
Neuroinflammation refers to activation of the immune system within the brain and central nervous system. This process involves immune cells such as microglia and astrocytes, which respond to infection, stress, or systemic inflammation.
In Lyme disease, this inflammatory signaling may persist beyond the initial infection, leading to ongoing changes in how the brain processes information.
Why neuroinflammation occurs in Lyme disease
Neuroinflammation in Lyme disease appears to result from ongoing immune signaling changes rather than a single isolated process.
- Persistent immune activation
- Cytokine signaling affecting brain function
- Altered blood-brain barrier dynamics
- Interaction between immune and autonomic systems
These factors can create a state where the brain remains in a heightened or dysregulated condition.
For a deeper look at inflammatory signaling, see The Cytokine Connection in Lyme Brain Fog.
How neuroinflammation affects cognition
Inflammation in the brain can interfere with communication between neural networks, affecting attention, memory, and processing speed.
Patients may experience:
- Brain fog
- Difficulty concentrating
- Slowed thinking
- Word-finding problems
- Mental fatigue
These symptoms are often subtle but can significantly affect daily functioning.
For a patient-centered overview, see Brain Fog and Lyme Disease.
Up to 90% of patients with post-treatment Lyme disease syndrome (PTLDS) report cognitive symptoms such as brain fog, memory issues, and slowed processing. Advanced imaging (PET, fMRI, DTI) in these patients shows evidence of inflammation, glial activation, and changes in white matter structure【source: Fallon et al., J Neuropsychiatry Clin Neurosci, 2008】.
Why brain fog can be mistaken for dementia
Neuroinflammation can produce symptoms that resemble more serious neurologic conditions, including memory loss and slowed thinking.
However, in Lyme disease these symptoms typically reflect functional changes rather than progressive neurodegeneration.
For a discussion of this distinction, see Lyme Disease and Dementia: When Brain Fog Isn’t Alzheimer’s.
Neuroinflammation and post-infectious syndromes
Similar patterns of cognitive symptoms have been observed following other infections, including COVID-19.
This overlap suggests that neuroinflammation may represent a broader post-infectious mechanism affecting brain function.
Learn more in Brain Fog in COVID-19 and Lyme Disease.
Interaction with autonomic dysfunction
Neuroinflammation also affects autonomic regulation, which controls blood flow, heart rate, digestion, and energy balance.
Disruption in these systems can reduce blood flow to the brain and worsen cognitive clarity.
This helps explain overlap with autonomic dysfunction in Lyme disease, including postural orthostatic tachycardia syndrome (POTS).
Why symptoms fluctuate
Neuroinflammation is dynamic, meaning symptoms often come and go.
Patients may notice:
- Periods of clarity followed by brain fog
- Worsening with stress or exertion
- Temporary improvement followed by relapse
This variability reflects changes in immune and nervous system signaling rather than permanent damage.
Fatigue in Lyme disease often reflects overlapping mechanisms involving inflammation, autonomic dysfunction, and sleep disruption. For a broader clinical perspective, see Lyme disease fatigue.
Clinical Insight
Neuroinflammation in Lyme disease does not require abnormal MRI findings or laboratory results. Many patients experience significant cognitive symptoms despite normal testing, reflecting functional changes in brain signaling rather than structural injury.
Why this matters clinically
Understanding neuroinflammation helps explain why cognitive symptoms persist and why they may not align with standard diagnostic findings.
This perspective shifts the focus from structural damage to functional and regulatory changes in the nervous system.
Clinical takeaway
Neuroinflammation in Lyme disease provides a central framework for understanding brain fog, cognitive dysfunction, and fluctuating neurologic symptoms.
Recognizing this mechanism connects immune dysregulation, autonomic dysfunction, and cognitive symptoms into a unified clinical picture.
Related
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
